We Showed That Exendin

Here, using a β-cell specific epidermal growth factor receptor (EGFR) null mouse, we show that exendin-4 induced an increase in proliferation and β-cell mass through EGFR. Thus, our study sheds light on the role of EGFR signaling in the effects of exendin-4 on the control of blood glucose metabolism and β-cell mass. Introduction

Weshowedthatthe constitutive GLP-1R activation by MSC-Ex-4-secreted Exendin-4 could delay cell senescence in both the β cells and the MSC-Ex-4, which is predominantly mediated by AMPK activation.

Wefurther confirmed the effect of exendin-4 treatment on GLP-1 receptor signaling and the resultsshowedan increase in the levels of cAMP against HG treatment consequent to activation of GLP-1 receptor signaling, which was antagonized byexendin- (9-39) (Fig. 1 C).

Wehere tested the hypothesis that multiple system atrophy is associated with brain insulin resistance andshowedincreased expression of the key downstream messenger insulin receptor substrate-1 phosphorylated at serine residue 312 in neurons and oligodendrocytes in the putamen of patients with multiple system atrophy.

Furthermore, visual representations like the one above help us fully grasp the concept of We Showed That Exendin.

In this study, we systematically demonstrated, through both in vitro and in vivo experiments, that Exendin-4 attenuates foam cell formation and inflammatory responses, with suppressing TREM2 expression in macrophages and inhibiting activation of the JAK2/STAT3 signaling pathway, thereby mitigating the progression of atherosclerosis (AS).